Recent Vaccine Development for Emerging Infectious Diseases

Dear Colleagues,

Emerging infectious diseases are infections that have recently appeared within a population or those whose incidence or geographic range is rapidly increasing or threatens to increase in the near future. Emerging infections can be caused by previously unknown infectious agents, known agents that have spread to new geographic locations or new populations, or the re-emergence of agents whose incidence of disease had significantly declined in the past, but whose incidence has reappeared.

The world is continuously facing the threats of emerging infectious diseases. COVID-19 has affected over 200 countries of the world and severely affected the healthcare and financial systems of both developed and developing countries. Monkeypox infections are also being reported from different countries and there has been a recent increase in cases of Ebola virus in Uganda. There is a strong need to understand the threats of emerging infectious diseases and have an effective global plan to develop vaccines for these diseases.

This Special Issue will cover clinical research, in silico studies, commentaries, and detailed review articles on vaccine development for emerging infectious diseases of both bacterial and viral origin. 

Prof. Dr. Yasir Waheed
Dr. Khalid Muhammad
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.